Journal article · 2023 · Open access
Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities
European Journal of Medicinal Chemistry, 259, 115709 · Published 3 August 2023 · DOI 10.1016/j.ejmech.2023.115709
In brief
“Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities” is a 2023 journal article by Pingyuan Wang and 14 co-authors, published in European Journal of Medicinal Chemistry. OpenAlex counts 16 citations as of 19 November 2026. It is open access: the full text is free to read at SSRN Electronic Journal.
- Citations
- 16
- Most cited in
- 2025 (7)
- Field-weighted impact
- 1.65
- References
- 57
- Authors
- 15
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Wang, P., Zhu, W.-T., Wang, Y., Song, S., Xi, Y., Yang, X., Shen, Y., Su, Y., Sun, Y.-M., Gao, Y., Chen, Y., Ding, J., Miao, Z., Zhang, A., & He, J. (2023). Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities. European Journal of Medicinal Chemistry, 259, 115709. https://doi.org/10.1016/j.ejmech.2023.115709
MLA 9
Wang, Pingyuan, et al. “Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities.” European Journal of Medicinal Chemistry, vol. 259, 2023, p. 115709. https://doi.org/10.1016/j.ejmech.2023.115709.
Chicago
Wang, Pingyuan, Wen-Ting Zhu, Yajing Wang, Shanshan Song, Yong Xi, Xinying Yang, Yanyan Shen, et al. 2023. “Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities.” European Journal of Medicinal Chemistry 259: 115709. https://doi.org/10.1016/j.ejmech.2023.115709.
Harvard
Wang, P. et al. (2023) ‘Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities’, European Journal of Medicinal Chemistry, 259, p. 115709. doi:10.1016/j.ejmech.2023.115709.
IEEE
P. Wang et al., “Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities,” European Journal of Medicinal Chemistry, vol. 259, p. 115709, 2023, doi: 10.1016/j.ejmech.2023.115709.
BibTeX
@article{wang2023identification,
title = {{Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities}},
author = {Wang, Pingyuan and Zhu, Wen-Ting and Wang, Yajing and Song, Shanshan and Xi, Yong and Yang, Xinying and Shen, Yanyan and Su, Yi and Sun, Yi-Ming and Gao, Yinglei and Chen, Yi and Ding, Jian and Miao, Ze‐Hong and Zhang, Ao and He, Jin‐Xue},
journal = {European Journal of Medicinal Chemistry},
year = {2023},
volume = {259},
pages = {115709},
doi = {10.1016/j.ejmech.2023.115709},
url = {https://doi.org/10.1016/j.ejmech.2023.115709}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 1 | |
| 2024 | 3 | |
| 2025 | 7 | |
| 2026 | 5 |
Its field-weighted citation impact is 1.65: it has been cited 1.65 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- PARP-1 inhibitors
- acquired drug resistance
- homologous recombination deficiency
- synthetic lethality
- MDA-MB-436 cells
- Capan-1 cells
- antiproliferative activity
- anticancer drug design
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Wang, P., Zhu, W.-T., Wang, Y., Song, S., Xi, Y., Yang, X., Shen, Y., Su, Y., Sun, Y.-M., Gao, Y., Chen, Y., Ding, J., Miao, Z., Zhang, A., & He, J. (2023). Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities. European Journal of Medicinal Chemistry, 259, 115709. https://doi.org/10.1016/j.ejmech.2023.115709
How many times has this paper been cited?
16 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at SSRN Electronic Journal: sign in and open the full text from this page.
Who wrote this paper?
Pingyuan Wang, Wen-Ting Zhu, Yajing Wang, Shanshan Song, Yong Xi, Xinying Yang, Yanyan Shen, Yi Su, Yi-Ming Sun, Yinglei Gao, Yi Chen, Jian Ding and 3 more.
What is the DOI of this paper?
10.1016/j.ejmech.2023.115709, permanently at https://doi.org/10.1016/j.ejmech.2023.115709. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.